Allen Nissenson

CIK 1441889 · Chief Medical Officer · last filed 2025-05-21

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.96M

Companies

4

Total Filings

31

Lifetime Open-Market Net

-$2.78M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RMTI Director 142,597 $0.62 $89.1K $0 7 2025-05-21
ELTX Director $14.85 $0 3 2025-05-20
Elicio Therapeutics, Inc. (ANGN) Delisted Director 9,383 $10.00 $93.8K $10.9K 3 2022-06-13
DVA Chief Medical Officer 8,990 $208.66 $1.88M -$2.79M 18 2014-02-18

Recent Filings · Page 2 of 4

31 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-03-10 Elicio Therapeutics, Inc. (ANGN) Delisted Grant (A) $0 EDGAR
2020-12-15 RMTI Grant (A) +1,488 $0 EDGAR
2020-06-12 RMTI Grant (A) +23,000 $0 EDGAR
2014-02-18 DVA Mixed +6,030 -$168.5K EDGAR
2013-12-18 DVA Mixed -$175.3K EDGAR
2013-05-15 DVA Mixed -$101.3K EDGAR
2013-03-22 DVA Grant (A) $0 EDGAR
2013-03-21 DVA Exer (M) $0 EDGAR
2013-03-08 DVA Mixed -$299.8K EDGAR
2012-12-20 DVA Grant (A) $0 EDGAR
Showing 1120 of 31
Page 2 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.